title: Exposure to hydroxyurea during pregnancy: a case series.
authors.forename: C
authors.initials: C
authors.lastname: Thauvin-Robinet
authors.forename: C
authors.initials: C
authors.lastname: Maingueneau
authors.forename: E
authors.initials: E
authors.lastname: Robert
authors.forename: E
authors.initials: E
authors.lastname: Elefant
authors.forename: H
authors.initials: H
authors.lastname: Guy
authors.forename: D
authors.initials: D
authors.lastname: Caillot
authors.forename: R O
authors.initials: RO
authors.lastname: Casasnovas
authors.forename: S
authors.initials: S
authors.lastname: Douvier
authors.forename: A
authors.initials: A
authors.lastname: Nivelon-Chevallier
mesh_terms: D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects* / Q000627:therapeutic use; D018811:Maternal Exposure; D008431:Maternal-Fetal Exchange; D009196:Myeloproliferative Disorders / Q000188:drug therapy*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D011256:Pregnancy Outcome
chemical_list: D006918:Hydroxyurea